Health Insurance Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Emory University, U.S.
Human papillomavirus vaccines are the focus of review
August 13th, 2006
A recent report discusses vaccines for the prevention of human papillomavirus and associated gynecologic diseases in a recent issue of Obstetrical and Gynecological Survey. According to the report, "Routine vaccination programs have had a substantial impact on reducing the prevalence of a variety of infectious diseases. In light of the fact that human papillomavirus (HPV) is a prerequisite for virtually every case of cervical cancer and genital warts occurring worldwide, vaccination may be the most effective mechanism to prevent HPV infection and HPV-associated disease. HPV vaccines are created from noninfectious virus-like particles (VLPs) of the major capsid...
Source: Health Insurance Law Weekly (2006-08-13)
|
